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SUMMARY
Neurocysticercosis (NCC) is one of the major causes of childhood seizures in developing countries including India and Latin 
America. In this study neurological pediatric cases presenting with afebrile seizures were screened for anti-Cysticercus antibodies 
(IgG) in their sera in order to estimate the possible burden of cysticercal etiology. The study included a total of 61 pediatric afebrile 
seizure subjects (aged one to 15 years old); there was a male predominance. All the sera were tested using a pre-evaluated commercially 
procured IgG-ELISA kit (UB-Magiwell Cysticercosis Kit TM). Anti-Cysticercus antibody in serum was positive in 23 of 61 (37.7%) 
cases. The majority of cases with a positive ELISA test presented with generalized seizure (52.17%), followed by complex partial 
seizure (26.08%), and simple partial seizure (21.73%). Headaches were the major complaint (73.91%). Other presentations were 
vomiting (47.82%), pallor (34.78%), altered sensorium (26.08%), and muscle weakness (13.04%). There was one hemiparesis case 
diagnosed to be NCC. In this study one child without any significant findings on imaging was also found to be positive by serology. 
There was a statistically significant association found between the cases with multiple lesions on the brain and the ELISA-positivity 
(p = 0.017). Overall positivity of the ELISA showed a potential cysticercal etiology. Hence, neurocysticercosis should be suspected 
in every child presenting with afebrile seizure especially with a radio-imaging supportive diagnosis in tropical developing countries 
or areas endemic for taeniasis/cysticercosis.
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INTRODUCTION
Worldwide, one third of the total epilepsy cases arise in childhood 
and neurocysticercosis (NCC) is the major cause  particularly in 
developing countries including India and Latin America20.30.34. NCC is 
caused by the metacestode larval stage of Taenia solium, and it affects 
patients of all ages4. In India, NCC is the most common cause of 
convulsions and hydrocephalus in adults and is the single most common 
cause of community acquired active epilepsy16,22. NCC patients may 
remain asymptomatic for months to years, and commonly a diagnosis 
is made incidentally when neuro-imaging is performed. However, its 
manifestations are variable and somewhat different when it occurs in 
children24,28. 
NCC in children is believed to be infrequent, but, as methods of 
diagnosis (imaging techniques and immunological tests) have improved, 
it has become possible to confirm more cases21. The serological tests 
are considered to be helpful as adjunct tests in order to confirm clinical 
diagnosis of NCC where Enzyme linked immunosorbent assay (ELISA) 
and enzyme linked immunotransfer blotting (EITB) are most frequently 
used for detection of antibodies in serum and/or CSF9,14,34. Though the 
latest diagnostic method approved by the Centers for Disease Control 
(CDC) for a confirmatory diagnosis of NCC is based on EITB, its cost and 
non availability of local suppliers limits its utility in India. In our study a 
sensitive ELISA kit is employed as a relatively lower cost screening test. 
There is insufficient information about NCC in children from Andhra 
Pradesh State in India. However, there are a couple of reports of T. solium 
cysticercosis in this state since a lot of adult cases of NCC as well as 
eye cases were reported earlier13,18,19 that indicate a possible prevalence 
of cysticercosis in children in the same region of this country. With this 
background, the objective of the present study was set to screen for anti-
Cysticercus antibodies in serum to estimate the NCC prevalence as an 
underlying etiology of afebrile seizure in children by ELISA.
MATERIALS AND METHODS
The present study was conducted in a teaching hospital in Andhra 
Pradesh Province in India after due approval of the protocol and 
permission where a total of 61 pediatric subjects presenting with afebrile 
seizure were recruited in a two years period. Informed consent was 
obtained from the parents or legal guardians of each of the study subjects. 
Detailed history was then collected from each patient and/or guardian/
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parents. Each child was clinically examined and 3mL blood samples were 
collected. The age range of patients was between one to 15 years with 
male predominance (male: female = 47:14). CT imaging was performed 
in all cases. The study subjects were initially hypothesized as possible 
cases of NCC based on two minor plus one epidemiological criteria as 
per the revised diagnostic criteria suggested elsewhere5.
A commercially procured ELISA kit (UB-Magiwell Cysticercosis 
Kit TM) was employed for detection of anti-Cysticercus antibodies in sera. 
All the collected sera were tested using the same ELISA kit following 
the manufacturer’s instructions. Antigen coated wells supplied by the 
kit manufacturer were incubated with 1:10 diluted patient/control serum 
(diluted with the serum diluent fluid provided in the kit). A negative 
control serum, a low positive control serum and a high positive control 
serum (all supplied by the manufacturer) were also used for validity of 
the test. Absorbance was measured at 492nm. A sample was considered 
positive for anti T. solium antibody when the OD value was estimated to 
be more than that of the low positive control serum. The sensitivity and 
specificity of the above ELISA for anti-Cysticercus antibody detection in 
serum was previously estimated to be 85% and 94% respectively based 
on results of the test using sera from a group of known cases (cases with a 
definitive diagnosis of NCC) and another group comprising healthy normal 
individuals as described in an earlier study25. Positive control sera were 
confirmed as positive by radio-imaging features as well as CDC approved 
EITB test using a commercially procured kit (Immunetics Inc, USA). 
RESULTS
A positive anti-Cysticercus IgG-ELISA result was observed in 23 
of the total 61 children indicating an overall positivity of 37.7% (Table 
1). The majority of cases with IgG-ELISA positive for Cysticercosis 
presented with generalized seizure (66.6%), followed by complex 
partial seizure (31.8%), and simple partial seizure (41.1%) (Table 1). 
The absorbance (OD
450
) for Low and High positive control sera was 
measured to be 0.807 and 1.139 respectively. As per the manufacturer’s 
specification, a case was confirmed as positive for anti-Cysticercus IgG 
antibody when its absorbance was observed to be greater than that of 
the Low positive control. A case was considered as borderline when 
its absorbance was observed to be same as that of the Low positive 
control. The mean OD
450
 values of the ELISA on sera identified to be 





=38 respectively) were further analyzed using GraphPad QuickCalcs 
free statistical calculators available on web (http://www.graphpad.
com/quickcalcs). The two-tailed p value was estimated to be less than 
0.0001, hence this difference was considered to be extremely statistically 
significant. Intermediate values used in these calculations: t = 6.0864; 
df = 16; Standard error of difference = 0.080. Confidence interval: 95% 
confidence interval of this difference: From -0.65452761 to -0.31636439. 
The pattern of seizure and other clinical manifestations in the 
recruited cases vs. the ELISA-positive cases (n = 61 and 23 respectively) 
are stated in Figure 1. Among the 23 cases with a positive ELISA result, 
the relative distribution of different seizure types was found to be similar 
to the overall cases. The majority of cases with IgG-ELISA positive for 
Cysticercosis presented with a generalized seizure (52.17%), followed by 
complex partial seizure (26.08%), and simple partial seizure (21.73%). 
Headaches were the major complaint (73.91%). Other presentations were 
vomiting (47.82%), pallor (34.78%), altered sensorium (26.08%), and 
muscle weakness (13.04%). There was one hemiparesis case diagnosed 
to be NCC. Results of the IgG-ELISA in patients with different patterns 
Table 1 
Results of anti-Cysticercus IgG-ELISA in patients with different patterns of seizure 





No. (%) of sera 
tested positive




Simple partial seizures 12 5 (41.1) 7 (58.9) χ2 = 0.45 
df = 2 
p = 0.798
Complex partial seizures 19 6 (31.8) 13 (68.2)
Generalized seizure 30 12 (66.6) 18 (33.4)
Total = 61 23 (37.7) 38 (62.3)
* p value was calculated based on non-parametric chi square analysis using Epi Info2001. No significance was estimated between the seizure patterns vs. antibody 
positivity (p = 0.798).
Fig. 1 - Distribution of clinical signs/symptoms, and seizure pattern in afebrile 
seizure cases diagnosed to be positive for anti-Cysticercus IgG-ELISA vs. all 
the recruited cases.
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of seizure showed predominance of generalized type but no statistical 
difference was observed (Table 1).
The CT scan findings i.e., number, distribution of lesions, and 
respective ELISA results are summarized in Table 2 and 3. The majority 
(n = 38) of the cases presented with a single space occupying lesion and 15 
cases with more than two lesions based on CT scan report. In eight cases the 
CT scan was reported normal; one child found to be positive by serology. 
The distribution of lesions in various parts of the brain showed the 
majority were in the parietal lobe followed by frontal, occipital, fronto-
parietal lobes (Table 3).
Of 23 positive cases, only 22 had a CT scan report showing presence 
of lesion(s) on the brain. The majority of cases had a calcified cyst 
(nine cases single and nine cases multiple). Among the cases with 
single or multiple lesions, the type of lesion and presence or absence 
of inflammation is shown in Table 4. There was active inflammation 
around the lesion in 11 cases (one vesicular, nine nodular cases) and 
four cases with calcified mass. None of the cases with vesicular lesion 
tested positive for antibody.
Among the positive cases there were 16 male and 7 female children. 
The overall age range of the patients was found to be one to 15 years 
(median age = 11 years). The age range of male cases was one to 
14 years (median age = 11 years) and the age range of female cases was 
from six to 15 years (median age = 12 years). 
DISCUSSION
NCC is the main cause of seizures in adults in many developing 
countries including South and Southeast Asia23. However, pediatric cases 
are seldom explored. Our study showed generalized seizures appeared 
in the majority of cases compared to partial seizures among the children 
presented to our pediatric epilepsy clinic. Results out of the present 
study supported the assumption that NCC can be a potential cause of 
childhood epilepsy particularly in tropical countries. In Mexico seizures 
were reported to be more frequent in children compared to adults, and 
intracranial hypertension and headaches were more frequent in adults24. 
In a study in Mexico, they identified different causes underlying the 
different distribution of seizures and intracranial hypertension in the two 
patient groups. But the situation has not been clarified for the pediatric 
population universally8. In a recent report from another Indian province, 
Table 2 
Results of anti-Cysticercus IgG-ELISA in patients with respect to CT scan imaging features
Total cases  
N
Anti-Cysticercus IgG-ELISA
No. (%) of sera 
tested positive 




Number of lesions in brain (n = 61)
Single lesion 38 12 (31.57) 26 (68.42) χ2 = 8.13 
df = 2 
p = 0.017
Multiple lesions 15 10 (66.66) 5 (33.33)
No lesion found (Normal Scan) 8 1 (12.5) 7 (87.5)
Overall result of 61 23 (37.7) 38 (62.29)
* p value was calculated based on non-parametric chi square analysis using Epi Info2001; there was a statistical difference between the cases with single lesion vs those 
with multiple lesions in brain and the ELISA-positive results (p = 0.017). ** Number of lesions, and location was based on the CT features and of 61 total number of 
cases 53 cases presented with either one or more number of lesions in the brain whereas eight cases did not show any lesion (normal scan); n = total number of cases.
Table 3
Results of anti-Cysticercus IgG-ELISA in patients with respect to location of lesions in brain
Total number of cases 
Anti-Cysticercus IgG-ELISA
No. (%) of sera 
tested positive 




Location of lesions in brain (n = 53) no lesion found in 8 cases
Parietal 27 12 (44.44) 15 (55.55)
χ2 = 0.9 
df = 3 
p = 0.826
Occipital 7 3 (42.82) 4 (57.14)
Fronto-perietal 6 3 (50) 3 (50)
Frontal 13 4 (30.76) 9 (69.23)
Overall result of 53 22 (41.5) 31 (58.49)
* p value was calculated based on non-parametric chi square analysis using Epi Info2001; no statistical difference was found when the relative distribution was com-
pared among different parts of the brain (p = 0.826). ** The lesion location was based on the CT features and of 53 cases presented with either one or more number of 
lesions in the brain; n = total number of cases.
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89.66% cases having neurological manifestations with inflammatory 
granulomas were found consistent with diagnosis of NCC1. However, 
the serodiagnostic confirmation was not performed in these cases. One 
strange case in the present series was a one year old patient that was 
diagnosed to be positive by serology. However a recent report of a 2-year-
old boy with diagnosis of NCC in Ecuador could support our finding 
that such a young child can also acquire this infection. The Ecuador case 
presented with two parenchymal brain ring-enhancing lesions and was 
confirmed by positive serology as well response to albendazole therapy 
where the patient’s mother was a Taenia solium carrier6. However, in the 
one year old child the source of infection was not identified since the 
mother refused to reveal her health history and, in addition that patient 
was referred elsewhere.
It has been accepted that the abrupt onset of clinical signs in human 
NCC coincides with intense pathologic reactions to degenerating 
metacestodes in the brain15. Following the death of all cysts, provoked 
seizures disappear, leaving a smaller percent of patients with residual 
epilepsy20. In the present study calcified lesions on the brain were 
observed in the majority of the cases which included either a single 
lesion or multiple ones, and also either with or without peri-lesional 
edema. Inflammation surrounding the lesions indicates the disease to 
be resulted primarily from the host inflammatory response to dying 
parasites as suggested elsewhere35. Generalized epilepsy was the most 
common clinical presentation in the present study. Earlier study also 
showed a predominance of generalized seizures compared to other clinical 
symptoms and also significantly higher titre in confirmed patients of NCC 
as compared to patients with other neurological disorders and normal 
controls26. Though NCC patients present with focal seizures the trend of 
generalized seizures to be the major presentation in children having NCC 
is contradictory to an earlier Indian study31. Hence, this study indicates 
that NCC should be suspected in every child with seizures especially in 
endemic areas. In the present study, only altered sensorium was found 
in 26.8% children with positive serology testing. Similar incidence was 
also reported in children from the earlier Indian study12.
In pediatric NCC patients, single colloidal parenchymal cysts were 
the most common radiologic findings compared with adults in whom 
multiple viable parasites in the basal subarachnoidal cisterns or in the 
ventricles were seen in Mexico24. An increased number of vesicular 
cysticerci and decreased number of degenerating cysticerci correlating 
with aging were noticed in earlier study, where immuno-endocrinological 
factors may be playing a role in susceptibility and pathogenesis7. 
However, in the present study, among the positively diagnosed children, 
we did not find any such trend. It may be clearer if we compare the 
prevalence among both children and adults in our future studies. We found 
the majority of cases had cyst(s) in the parietal region of the brain. In 
an earlier report from India it was hypothesized that a child with partial 
seizures with no obvious causation has a high probability of harboring 
one of these three lesions viz., single CT enhancing lesion, single small 
cerebral calcific CT lesion, and multiple small cerebral calcific CT 
lesions17. NCC, single CT enhancing lesion and small single cerebral 
calcific CT lesion together accounted for 40% of etiological factors 
of seizure as reported in a retrospective study by the same group from 
India18. Extraparenchymal NCC is rare in children and carries a poor 
prognosis29. Also, no extraparenchymal cysticercosis was reported in 
the present series. However, frequent reporting of cysticercosis in eyes, 
from the same region of this country indicates the possible prevalence 
of cysticercosis in children18. 
This is the first report of cysticercal etiology of childhood epilepsy 
from this particular territory. There were a few earlier reports from other 
provinces in the country showing a similar occurrence of cysticercal 
etiology of childhood seizure11,33. NCC has been diagnosed on imaging 
studies in 34.6% of patients with seizure disorder of any type, 59.2% of 
those with a single seizure, 23.7% of those with recurrent seizure disorder 
as reported in a recent review27. In the present study, NCC is found to be 
the etiologic factor in 37.7% among the patients presenting with seizures 
and we did not include any adult case in this survey. The majority of our 
patients were drawn from the rural population with agriculture and animal 
farming background. Analysis based on earlier studies indicates that NCC 
should be suspected in every child with seizures and seroepidemiological 
study may be concluded for the ultimate control of the disease26. Thus, 
NCC must be considered in the differential diagnosis of seizures and a 
wide variety of neurologic disorders, particularly in endemic areas29. 
We analyzed the social customs and related factors which are peculiar 
to this region and were indirectly responsible for the high incidence of 
cysticercosis (data not presented). Usually, the highest prevalence rates 
exist in communities where there is close contact between man and pigs, 
hygienic standards are low, and pork is eaten as raw or undercooked. 
In Southern India, NCC was found in 2.2% of epilepsy cases. A study 
from Northern India indicated that cerebral cysticercosis was found in 
11.1% amongst those attending the neurology clinic and 17.4%-19.2% 
of clinically suspected patients. An earlier study from endemic villages 
report up to 10% or more of the general population having antibodies to T. 
solium, not necessarily reflecting the true prevalence of the cysticercosis 
and leading to misdiagnosis in a proportion of neurological cases2. So, 
a community approach may help with estimating the true prevalence of 
cysticercosis.
Sensitivity and specificity of the presently used commercial ELISA 
Table 4 













Calcified cyst (single) 9 (40.9)
> 1 lesions
Calcified cysts (> 1) 9 (40.9)
Calcified + granular nodular 
stage (with inflammation)
1 (4.5)
Total number of positive cases 
with brain lesion
22
* p value was calculated and analyzed using GraphPad QuickCalcs free statistical 
calculators; no statistical difference was found when the types of lesions (calci-
fied lesions only vs. non-calcified lesions) were compared with respect to ELISA 
positivity. The two-tailed p value equals 0.7215. ** The type of lesion was based 
on the CT features following the criteria as described elsewhere
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in serum reported to be 85% and 94% respectively in our previous 
study25. In another Indian study, ELISA kit from the same manufacturer 
was reported to be of similar sensitivity and specificity3. Previously 
we demonstrated 80%, and 90% sensitivity of in-house dot-ELISAs 
when T. solium metacestode somatic, and ES respectively were used 
(data unpublished). Specificities of this in house Dot-ELISAs using T. 
solium metacestode somatic and ES antigens were observed to be 90% 
in each case. Sensitivity of the employed ELISA kit for anti-Cysticercus 
antibody detection as previously estimated was based on results of the 
test using sera from cases with a definitive diagnosis of NCC25. However, 
in the present study the test was employed to screen for anti-Cysticercus 
antibody in serum from patients presenting with afebrile seizure and 
in all suspected cases without any definitive diagnosis of NCC. Hence 
in the present screening study, we could diagnose only 37.7% cases to 
be positive for the said ELISA test. It is also true that the rest of the 
cases were negative for the anti-Cysticercus antibody which means 
the underlying cause of NCC in those cases could not be established 
otherwise possibly there may be other etiology in those cases. However, 
the importance of NCC as one of the underlying causes of acute afebrile 
seizure in pediatric patients could be highlighted in our study. 
Usually, determination of the prevalence of an infection is hampered 
by variable sensitivity and specificity of each of the diagnostic tests 
used, which identify a limited or overlapping proportion of its true 
prevalence. There may be discrepancy between radio-imaging based 
on suspicion of NCC vs. a serological test result. The majority of 
NCC cases do not always show typical neuro-imaging features and 
solitary brain lesion which is a diagnostic challenge10. Hence it is 
important for the clinician to choose an appropriate imaging modality 
for a proper diagnosis of the etiology in seizure patients. Sensitivity 
of a test detecting antibodies for the parasite is also related to the 
number of lesions present on the brain as found in our study. There 
was a statistically significant association found between the cases 
with multiple lesions in brain and the ELISA-positivity (p = 0.017). 
It may be due to a release of more antigens from multiple larvae that 
results in mounting a stronger antibody response in the infected host 
as suggested in a recent article36.
The presence of antibodies was assessed among all the cases either 
having intracranial lesion or no lesion after brain imaging; it was done 
to employ the use of serological investigation in the diagnosis of NCC 
before using imaging. The one child who had no abnormality on their 
brain CT but was found to be ELISA positive was of interest. This 
child responded to the albendazole therapy and after follow up, there 
was a significant decrease in antibody titre for the above case (data 
not shown). However, it could only support the fact that the studied 
population had an exposure to the parasite. However, detection of 
antibodies with a different rationale may be considered indicative of 
the active infection. An early and appropriate diagnosis, revealing 
the biological stage of the parasite would be of value in initiating an 
appropriate treatment. Moreover, it would be useful in population 
screening, diagnosis and post-treatment monitoring of NCC especially 
in the situations where imaging techniques are either not available or 
inconclusive. 
LIMITATION
The prevalence of anti-Cysticercus antibodies detected in sera from 
the randomly selected children with afebrile seizure may not be the true 
picture if the figures are extrapolated to a larger population in the territory. 
The kit detects antibodies against antigens of the parasite which are not 
defined. Further study should be conducted to screen antibodies specific 
to more defined antigens of the larval parasite. 
CONCLUSION
Detecting anti-Cysticercus IgG antibodies in serum could reveal 
the potentiality of possible NCC as an underlying cause of afebrile 
seizures in the studied pediatric cases. Although, the CT scan is a potent 
diagnostic tool compared to antibody detection, the diagnostic decision 
can be better made when both the modalities are considered together. 
Nevertheless NCC may be suspected as one of the major etiology and 
hence should be ruled out in every afebrile seizures case, with or without 
a radioimaging supportive diagnosis, especially in areas endemic for 
taeniasis/cysticercosis.
RESUMO
Neurocisticercose em crianças apresentando crises afebris: perfil 
clínico, imagem e sorodiagnóstico
Neurocisticercose é uma das causas mais comuns de crises em 
crianças em países em desenvolvimento incluindo Índia e América 
Latina. Neste estudo casos neurológicos pediátricos, apresentando 
crises afebris foram selecionados através de anticorpos anti-Cysticercus 
(IgG) no seu soro para avaliar possível etiologia de Cysticercus. O 
estudo incluiu total de 61 casos pediátricos de indivíduos com crises 
afebris (idade de um a 15 anos); houve predominância de pacientes 
do sexo masculino. Todos os soros foram testados usando um kit 
comercial IgG-ELISA (UB-Magiwell Cysticercosis kitTM) avaliado 
previamente. O anticorpo anti-Cysticercus no soro foi positivo em 
23 de 61 casos (37,7%). A maioria dos casos com teste de ELISA 
positivo apresentava crises generalizadas (52,17%), seguida por 
casos de crises parciais complexas (26,08%) e crises parciais simples 
(21,73%). Dores de cabeça foram a queixa principal (73,91%). Outras 
manifestações foram vômitos (47,82%), palidez (34,78%), sensório 
alterado (26,08%) e fraqueza muscular (13,04%). Houve um caso 
de hemiparesia diagnosticado como NCC. Neste estudo uma criança 
sem quaisquer achados significantes às imagens apresentou sorologia 
positiva. Houve associação estatística significante entre os casos com 
múltiplas lesões no cérebro e a positividade pelo ELISA (p = 0,017). No 
seu conjunto a positividade pelo ELISA demonstra etiologia potencial 
para a cisticercose. Portanto neurocisticercose deve ser suspeitada em 
qualquer criança apresentado crises afebris com imagem que sugira 
diagnóstico em países tropicais em desenvolvimento ou em áreas 
endêmicas para teníase/cisticercose. 
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